Biofilms: New ideas for an old problem

Recent Patents on Biotechnology

Volumn 6, Issue 1, 2012, Pages 13-22

  de Carvalho, Carla C C R ^a,b  

^a Instituto de Biotecnologia e Bioengenharia Lisboa   (Portugal)

^b INSTITUTO SUPERIOR TÉCNICO   (Portugal)

Author keywords

Antimicrobial surface; Biocide; Biofilm; Catheter; Cell adhesion; Decontamination; Detergent; Deterrence; Disinfection; Exopolymeric matrix; Haemodialysis; Medical devices; Micro organism; Ultra pure water; Water supply

Indexed keywords

BIOFILMS; BIOMEDICAL EQUIPMENT; CELLS; DISINFECTION; MASS TRANSFER; WATER SUPPLY;

ANTIMICROBIAL SURFACE; CELLS ADHESION; DETERRENCE; EXOPOLYMERIC MATRIX; HAEMODIALYSIS; MATRIX; MEDICAL DEVICES; MICRO-ORGANISMS; MICROBIAL CELLS; ULTRA-PURE WATER;

CELL ADHESION;

ANTIBIOTIC AGENT; BIOCIDE; OLIGOPEPTIDE; PEPTIDOMIMETIC AGENT; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT; QUATERNARY AMMONIUM DERIVATIVE; SILVER;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOPHAGE; BACTERIUM ADHERENCE; BACTERIUM CONTAMINATION; BIOFILM; CELL ADHESION; DISINFECTION; HUMAN; MATERIAL COATING; MEDICAL DEVICE; NONHUMAN; PATENT; PRIORITY JOURNAL; QUORUM SENSING; SURFACE PROPERTY;

BACTERIA (MICROORGANISMS);

EID: 84858327955     PISSN: 18722083     EISSN: None     Source Type: Journal    
DOI: 10.2174/187220812799789163     Document Type: Article

References (131)

1. Flemming HC, Wingender J. The biofilm matrix. Nature Reviews Microbiology 2010; 8: 623-33.
2. Flemming H-C, Neu TR, Wozniak DJ. The EPS Matrix: The "House of Biofilm Cells". J Bacteriol 2007; 189: 7945-7.
3. Ivanova EP, Vu B, Chen M, Crawford RJ. Bacterial extracellular polysaccharides involved in biofilm formation. Molecules 2009; 14: 2535-54.
4. Kumar MA, Anandapandian KTK, Parthiban K. Production and characterization of exopolysaccharides (EPS) from biofilm forming marine bacterium. Brazilian Archives of Biology and Technology 2011; 54: 259-65.
5. Behlau I, Mukherjee K, Todani A, Tisdale AS, Cade F, Wang L, Leonard EM, Zakka FR, Gilmore MS, Jakobiec FA, Dohlman CH, Klibanov AM. Biocompatibility and biofilm inhibition of N, Nhexyl, methyl-polyethylenimine bonded to Boston Keratoprosthesis materials. Biomaterials 2011; 32: 8783-96.
6. Di Cagno R, De Angelis M, Calasso M, Gobbetti M. Proteomics of the bacterial cross-talk by quorum sensing. Journal of Proteomics 2011; 74: 19-34.
7. Wilmes P, Remis JP, Hwang M, Auer M, Thelen MP, Banfield JF. Natural acidophilic biofilm communities reflect distinct organismal and functional organization. Isme Journal 2009; 3: 266-70.
8. Bryers JD. Medical biofilms. Biotechnology and Bioengineering 2008; 100: 1-18.
9. ECDC. Annual epidemiological report on communicable diseases in Europe. European Centre for Disease Prevention and Control. Revised edition. Stockholm, pp. 221, 2009.
10. Lynch AS, Robertson GT. Bacterial and fungal biofilm infections. Annual Review of Medicine 2008; 59: 415-28.
11. Otto K. Biophysical approaches to study the dynamic process of bacterial adhesion. Research in Microbiology 2008; 159: 415-22.
12. Klemm P, Vejborg R, Hancock V. Prevention of bacterial adhesion. Applied Microbiology and Biotechnology 2010; 88: 451-9.
13. Xiong YH, Liu Y. Biological control of microbial attachment: a promising alternative for mitigating membrane biofouling. Applied Microbiology and Biotechnology 2010; 86: 825-37.
14. Li WKW, Dickie PM. Distribution and abundance of bacteria in the ocean. Bedford Institute of Oceanography, Gulf Fisheries Centre, the Halifax Fisheries Research Laboratory, and the St. Andrews Biological Station. 1996-1997.
15. Belkaid S, Ladjouzi MA, Hamdani S. Effect of biofilm on naval steel corrosion in natural seawater. Journal of Solid State Electrochemistry 2011; 15: 525-37.
16. Duan JZ, Wu SR, Zhang XJ, Huang GQ, Du M, Hou BR. Corrosion of carbon steel influenced by anaerobic biofilm in natural seawater. Electrochimica Acta 2008; 54: 22-8.
17. Jayaraman A, Earthman JC, Wood TK. Corrosion inhibition by aerobic biofilms on SAE 1018 steel. Applied Microbiology and Biotechnology 1997; 47: 62-8.
18. Zuo R. Biofilms: strategies for metal corrosion inhibition employing microorganisms. Applied Microbiology and Biotechnology 2007; 76: 1245-53.
19. Alvarez-Lorenzo C, Contreras-Garcia A, Bucio E, Brackman G, Coenye T, Concheiro A. Biofilm inhibition and drug-eluting properties of novel DMAEMA-modified polyethylene and silicone rubber surfaces. Biofouling 2011; 27: 123-35.
20. Anderson JM, Patel JD, Ebert M, Ward R. S-epidermidis biofilm formation: effects of biomaterial surface chemistry and serum proteins. Journal of Biomedical Materials Research Part A 2007; 80A: 742-51.
21. Banerjee I, Pangule RC, Kane RS. Antifouling coatings: recent developments in the design of surfaces that prevent fouling by proteins, bacteria, and marine organisms. Advanced Materials 2011; 23: 690-718.
22. Boy J, Breves R, Lueken M, Stumpe S, Weide M, Wrubbel N. Use of copolymers of ethylenically unsaturated monomer to reduce the adhesion of microorganisms and/or to reduce the formation of biofilms on surfaces, and to treat and/or prevent bacterial or fungal infections. DE 2007/058342-A1; WO 2009/071451-A2; WO 2009/071451-A3; EP 2215134-A2; US 2010/249249-A1, 2009.
23. Derby C, Ko K-C, Kamio M, Wang B, Tai PC. Antimicrobial compositions and methods of use. WO 2010/011998-A1; WO 2010/011998-A9; AU 2009/273804-A1; CA 2730343-A1, 2010.
24. Groll J, Fiedler J, Bruellhoff K, Moeller M, Brenner RE. Novel surface coatings modulating eukaryotic cell adhesion and prevent ing implant infection. International Journal of Artificial Organs 2009; 32: 655-62.
25. Hannig M, Kriener L, Hoth-Hannig W, Becker-Willinger C, Schmidt H. Influence of nanocomposite surface coating on biofilm formation in situ. Journal of Nanoscience and Nanotechnology 2007; 7: 4642-8.
26. Ista LK, Mendez S, Balamurugan SS, Balamurugan S, Rao VGR, Lopez GP. Smart surfaces for the control of bacterial attachment and biofilm accumulation. Smart Coatings Ii 2009; 1002: 95-110.
27. Li DY, Yu B, Davis EM, Hodges RS, Irvin RT. Surface nanocrystallization of stainless steel for reduced biofilm adherence. Nanotechnology 2008; 19:
28. Pradier CM, Caro A, Humblot V, Methivier C, Minier M, Salmain M. Grafting of lysozyme and/or poly(ethylene glycol) to prevent biofilm growth on stainless steel surfaces. Journal of Physical Chemistry B 2009; 113: 2101-9.
29. Tolker-Nielsen T, Chiang WC, Schroll C, Hilbert LR, Moller P. Silver-palladium surfaces inhibit biofilm formation. Applied and Environmental Microbiology 2009; 75: 1674-8.
30. Bennett-Guerrero E, Pappas TN, Koltun WA, Fleshman JW, Lin M, Garg J, al. e. For the SWIPE 2 Trial Group, Gentamicincollagen sponge for infection prophylaxis in colorectal surgery. N Engl J Med 2010; 363: 1038-49.
31. O'Shaughnessey WS, Zhang Z, Hencke M, Wood K, Squier T, Loose CR. Non-leaching non-fouling antimicrobial coatings. US 2009/0155335 A1, 2009.
32. Gobin AS. Silk fibroin coating. US 2009/0162439 A1, 2009.
33. Dhende VP, Samanta S, Jones DM, Hardin IR, Locklin J. One-step photochemical synthesis of permanent, nonleaching, ultrathin antimicrobial coatings for textiles and plastics. ACS Applied Materials & Interfaces 2011; 3: 2830-7.
34. Hoffmann C, Cahill WR, Malone SF, Erkenbrecher CW. Removable antimicrobial coating compositions containing acid-activated rheology agent and methods of use. WO 2011/017090-A1, 2011.
35. Cook G, Trebella M. Antimicrobial coating for inhibition of bacterial adhesion and biofilm formation. US 2008/0063693 A1, 2008.
36. Matsuda T, Maeyama R. Biofilm formation inhibitor and treatment device thereof. US 2009/0099646, 2009.
37. Stumpe S, Hätzelt A, Breves R, Weide M, Boy J, Lüken M. Reduction of the adhesion of dirt, dust and biological material by means of polyester amides. WO 2009/071452 A2, 2009.
38. Baum R, Antoni-Zimmermann D, Wunder T, Schmidt H-J. Coating material with biocide microcapsules. US 2008/7429392 B2, 2008.
39. Musee N, Thwala M, Nota N. The antibacterial effects of engineered nanomaterials: implications for wastewater treatment plants. Journal of Environmental Monitoring 2011; 13: 1164-83.
40. Upadhyayula VKK, Gadhamshetty V. Appreciating the role of carbon nanotube composites in preventing biofouling and promoting biofilms on material surfaces in environmental engineering: A review. Biotechnology Advances 2010; 28: 802-16.
41. Douglas T, Young MJ, Suci P. Novel nanoparticles for biofilm targeting. WO 2008/08105902; US 2010/0021391 A1, 2008.
42. Stafslien S, Daniels J, Chisholm B, Christianson D. Combinatorial materials research applied to the development of new surface coatings III. Utilisation of a high-throughput multiwell plate screening method to rapidly assess bacterial biofilm retention on antifouling surfaces. Biofouling 2007; 23: 37-44.
43. Ren D, Zhang M, Niepa T, Gilbert J. System and method for controlling bacterial persister cells with weak electric currents. 2011.
44. Grass G, Rensing C, Solioz M. Metallic copper as an antimicrobial surface. Appl Environ Microbiol 2011; 77: 1541-7.
45. de Carvalho CCCR, Caramujo MJ. Ancient procedures for the high-tech world: health benefits and antimicrobial compounds from the Mediteranean Empires. The Open Biotechnology Journal 2008; 2: 235-46.
46. EPA. Available at: http://www.epa.gov/pesticides/factsheets/ copper-alloy-products.htm (Accessed on: 07-07-2011).
47. Noyce JO, Michels HT, Keevil CW. Potential use of copper surfaces to reduce survival of epidemic meticillin-resistant Staphylococcus aureus in the healthcare environment. Journal of Hospital Infections 2006; 63: 289-97.
48. Kuhn PJ. Doorknobs: a source of nosocomial infection? Diagn Med 1983; 6: 62-3.
49. Airey P, Verran J. Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. Journal of Hospital Infections 2007; 67: 271-7.
50. Bragg PD, Rainnie DJ. Effect of silver ions on respiratory-chain of Escherichia coli. Canadian Journal of Microbiology 1974; 20: 883-9.
51. Kumar VS, Nagaraja BM, Shashikala V, Padmasri AH, Madhavendra SS, Raju BD, Rao KSR. Highly efficient Ag/C catalyst prepared by electro-chemical deposition method in controlling microorganisms in water. Journal of Molecular Catalysis A: Chemical 2004; 223: 313-9.
52. Dworniczek E, Nawrot U, Seniuk A, Wlodarczyk K, Bialynicki-Birula R. The in Vitro Effect of a Silver-Containing Dressing on Biofilm Development. Advances in Clinical and Experimental Medicine 2009; 18: 277-81.
53. Martinuzzi RJ, Kostenko V, Lyczak J, Turner K. Impact of silvercontaining wound dressings on bacterial biofilm viability and susceptibility to antibiotics during prolonged treatment. Antimicrobial Agents and Chemotherapy 2010; 54: 5120-31.
54. Gawande P, Madhyastha S, Lovetri K, Yakandawala N, Froehlich G. Biofilm-removing antimicrobial compositions and uses thereof. WO 2010/083589, 2010.
55. Pichette C, Zhang H, Davison W, Sauvé S. Preventing biofilm development on DGT devices using metals and antibiotics. Talanta 2007; 72: 716-22.
56. Saleh S, Sweileh B, Taha SO, Mahmoud R, Taha MO. Preparation of polyester-based metal-cross linked polymeric composites as novel materials resistant to bacterial adhesion and biofilm formation. Molecules 2011; 16: 933-50.
57. Kanematsu H, Ikigai H, Yoshitake M. Evaluation of various metallic coatings on steel to mitigate biofilm formation. International Journal of Molecular Sciences 2009; 10: 559-71.
58. Thomas CM, Ma Y. Condensing heat exchanger with hydrophilic antimicrobial coating. US 2009/314469-A1, 2009.
59. Secinti KD, Ozalp H, Attar A, Sargon MF. Nanoparticle silver ion coatings inhibit biofilm formation on titanium implants. Journal of Clinical Neuroscience 2011; 18: 391-5.
60. Neut D, Hosman AH, van der Mei HC, Bulstra SK, Busscher HJ. Metal-on-metal bearings in total hip arthroplasties: Influence of cobalt chromium ions on bacterial growth and biofilm formation. Journal of Biomedical Materials Research Part A 2009; 88A: 711-6.
61. Al-Ahmad A, Wiedmann-Al-Ahmad M, Faust J, Bachle M, Follo M, Wolkewitz M, Hannig C, Hellwig E, Carvalho C, Kohal R. Biofilm formation and composition on different implant materials in vivo. Journal of Biomedical Materials Research Part B-Applied Biomaterials 2010; 95B: 101-9.
62. Mikulewicz M, Chojnacka K. Release of metal ions from orthodontic appliances by in vitro studies: A systematic literature review. Biological Trace Element Research 2011; 139: 241-56.
63. McHatton S, Williams IM, Drahos D. Preventing and reducing biofilm formation and planktonic proliferation. US 2008/0233093; WO 2008/118749, 2008.
64. Cateau E, Berjeaud JM, Rodier MH, Imbert C. Fungal biofilm inhibition by a component naturally produced by Candida albicans yeasts growing as a biofilm. International Journal of Antimicrobial Agents 2008; 31: 166-70.
65. Zuo R. Biofilms: strategies for metal corrosion inhibition employing microorganisms. Applied Microbiology and Biotechnology 2007; 76: 1245-53.
66. Kaplan JB. Biofilm Dispersal: Mechanisms, Clinical Implications, and Potential Therapeutic Uses. Journal of Dental Research 2010; 89: 205-18.
67. Kaplan JB. Therapeutic potential of biofilm-dispersing enzymes. International Journal of Artificial Organs 2009; 32: 545-54.
68. Molobela IP, Cloete TE, Beukes M. Protease and amylase enzymes for biofilm removal and degradation of extracellular polymeric substances (EPS) produced by Pseudomonas fluorescens bacteria. African Journal of Microbiology Research 2010; 4: 1515-24.
69. Deinhammer R, Andersen C. Methods for preventing, removing, reducing, or disrupting biofilm. US 2011/0104141; WO 2006/ 031554, 2011.
70. Barnett C, Kumar M, Whited GM. Enzymatic prevention and control of biofilm. WO 2009/085743 A1, 2009.
71. Kumar M. Enzymatic prevention and control of biofilm. WO 2008/013747, 2008.
72. Pellico M. Use of hydrolytic and oxidative enzymes to dissolve biofilm in ears. WO 2008/070387, 2008.
73. Ammendola A. Inhibitors of fungal biofilm formation. EP 2009/2070527 A1, 2009.
74. Cohen NA, O'Malley BW, Jr., Chiu AG, Palmer JN, Steiger JD. Biofilm prevention using lactoferrin. WO 2009/09009065, US 2010/0298208 A1, 2009.
75. Isobe K, Okauchi Y. Biofilm-removing agent. WO 2009/069296, 2009.
76. Whitekettle WK, Tafel GJ, Zhao Q, Wang L, Reynolds D, Frail P, Jiang J, Polizzotti DM. Controlling fouling of an aqueous system including a biofilm matrix and microorganisms in contact with the matrix, comprises providing a biofilm control agent in a vesicle and adding the vesicle to the aqueous system. US 2011/052656-A1, 2011.
77. Suga H, Igarashi J. Biofilm remover useful in the treatment of intractable biofilm infections comprises amide compound as active ingredient. US2008241081-A1, 2008.
78. Shin H, Hwang H, Lee H, Kim S, Park Y, Cheon H, Shin HC, Hwang HJ, U. LH, Kim SH, Park YJ, Cheon HC. Composition useful for the management and improvement of oral health, and prevention of gum diseases, gingivitis and periodontal diseases, comprises dibenzo-p-dioxin derivative as active ingredients. WO 2010/150944-A1; KR 2010/138227-A, 2011.
79. Li MY, Lai GY, Wang J, Ye DX. The inhibition of eugenol on glucan is essential for the biofilm eradication effect on cariesrelated biofilm in an artificial mouth model. Natural Product Research 2011; 1-4.
80. David D. Induction of a physiological dispersion response in bacterial cells in a biofilm. US 2007/0207095 A1, 2007.
81. Isobe K, Okano T, Iwasaki S, Okauchi Y. Composition of biofilm control agent. US 2009/0123449; WO 2007/123271, 2009.
82. Marion K. Method for eliminating biofilm. EP 2009/1556466, 2009.
83. Aggarwal D, Shah CB. Antimicrobial and anticoagulant compositions and methods. US 2010/022652-A1; WO 2010/014306-A1, 2010.
84. Beardwood ES, Hays GF, Colby SJ, Emerich DE. Process for inhibiting biofilm formation on and/or removing biofilm from an enhanced tube. WO 2006/105369, 2008.
85. Coughlin MF. Non-aqueous chlorine dioxide solution useful for disinfecting object e.g. food product, plant, mechanical device, comprises chlorine dioxide and a non-aqueous carboxylic acid. WO 2009/117581-A2; WO 2009/117581-A3; EP 2262372-A2; US 2011/020472-A1, 2009.
86. Kim M, Park J-M, Um H-J, Lee K-H, Kim H, Min J, Kim Y-H. The antifouling potentiality of galactosamine characterized from Vibrio vulnificus exopolysaccharide. Biofouling 2011; 27: 851-7.
87. Abedon ST, Thomas-Abedon C. Phage Therapy Pharmacology. Current Pharmaceutical Biotechnology 2010; 11: 28-47.
88. Cornelissen A, Ceyssens PJ, T'Syen J, Van Praet H, Noben JP, Shaburova OV, Krylov VN, Volckaert G, Lavigne R. The T7-Related Pseudomonas putida phage phi 15 displays virionassociated biofilm degradation properties. Plos One 2011; 6: e18597.
89. Donlan RM. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends in Microbiology 2009; 17: 66-72.
90. Chhibber S, Bedi MS, Verma V. Amoxicillin and specific bacteriophage can be used together for eradication of biofilm of Klebsiella pneumoniae B5055. World Journal of Microbiology & Biotechnology 2009; 25: 1145-51.
91. Chhibber S, Verma V, Harjai K. Restricting ciprofloxacin-induced resistant variant formation in biofilm of Klebsiella pneumoniae B5055 by complementary bacteriophage treatment. Journal of Antimicrobial Chemotherapy 2009; 64: 1212-8.
92. Yoon S, Choi Y, Lee SJ, Son J, Jun S, Kang S. Bacteriophage or lytic protein derived from the bacteriophage which effective for treatment of Staphylococcus aureus biofilm. US 2010/0254950-A1, 2010.
93. Pasternack G, Sulakvelidze A, Pasternack GR. New bacteriophage composition comprising Listeria monocytogenes bacteriophage strains having specific accession numbers, for controlling growth of contamination of food products, for treating host infection or environmental contamination. US 2008/194000-A1; WO 2008/100273-A1; US 2008/7507571-B2 2008.
94. Balaban N, Kiran MD, Giacometti A, Cirioni O. Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. International Journal of Artificial Organs 2008; 31: 761-70.
95. Bassler BL, Waters CA, Lu WY, Rabinowitz JD. Quorum sensing controls biofilm formation in Vibrio cholerae through modulation of cyclic Di-GMT levels and repression of vpsT. Journal of Bacteriology 2008; 190: 2527-36.
96. Bjarnsholt T, Christensen LD, Moser C, Jensen PO, Rasmussen TB, Christophersen L, Kielleberg S, Kumar N, Hoiby N, Givskov M. Impact of Pseudomonas aeruginosa quorum sensing on biofilm persistence in an in vivo intraperitoneal foreign-body infection model. Microbiology-Sgm 2007; 153: 2312-20.
97. Coenye T, Brackman G, Hillaert U, Van Calenbergh S, Nelis HJ. Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia. Research in Microbiology 2009; 160: 144-51.
98. Martin CA, Hoven AD, Cook AM. Therapeutic frontiers: preventing and treating infectious diseases by inhibiting bacterial quorum sensing. European Journal of Clinical Microbiology & Infectious Diseases 2008; 27: 635-42.
99. Charlton KA, Porter A, Thornthwaite L. Methods for reducing biofilm formation in infectious bacteria. EP 2011/2281839, 2011.
100. Thornthwaite L, Charlton K, Porter A. Methods for reducing biofilm formation in infectious bacteria. US 2009/0117109 A1, 2007.
101. Meijler MM, Amara N, Rayo J. Covalent inhibition of bacterial quorum sensing. WO 2011/001419, 2011.
102. Ammendola A, Wieber T, Wuzik A, Lang M. Inhibitors of biofilm formation of gram-positive and gram-negative bacteria, EP 2070527 2009.
103. Yoon J-Y, Kim C-J, Kim J-E, Park H-Y. Quorum sensing antagonist, method of preventing a biofilm formation using the quorum sensing antagonist and method of reducing a bacterial contamination using the quorum sensing antagonist. WO 2008/069374, 2008.
104. Hermans PWM, Van Eldere J. Prevention of Staphylococcus biofilm formation. US 2010/0291177; WO 2008/127099, 2010.
105. Ramirez-Arcos SM, Maurer E, Scott M. Prevention of biofilm formation using pegylated blood products. EP 2008/1935426, 2008.
106. Bornstein ES. Optical biofilm therapeutic treatment. US 2008/0077204 A1, WO 2008/08013792, 2008.
107. Bates BL, Hiles MC, Johnson CE. Biofilm inhibiting medical products. US 2008/0181950 A1, WO 2008/08092011, 2008.
108. Teles RP, Teles FRF. Antimicrobial agents used in the control of periodontal biofilms: effective adjuncts to mechanical plaque control? Braz Oral Res 2009; 23 Suppl 1: 39-48.
109. Demuth DR, Daep CA. Synthetic peptides. WO 2009/108716-A2; WO 2009/108716-A3, 2009.
110. Dashper SG, Reynolds EC, Veith PD, Ang CS. Biofilm treatment. US 2010/0209362 A1, 2010.
111. Gottenbos B, Bohmer MR, Janssen JJM. Antimicrobial filled capsules in an ultrasound field for treatment of dental biofilm. WO 2009/09077921, 2009.
112. Bornstein E. Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis. US 2008/0138772 A1, EP 2008/1732463, 2009.
113. Slenker DE, Prisco JR, Lewis CO, Norman GW, Vaccaro RK, Perry IC. Surgical instrument, system, and methos for biofilm removal. US 2008/0167527-A1, 2008.
114. Av-Gay Y, Mahler L, Miller CC. Biofilm inhibiting catheters and tubings. WO 2009/09124379, 2009.
115. Cirioni O, Ghiselli R, Minardi D, Orlando F, Mocchegiani F, Silvestri C, Muzzonigro G, Saba V, Scalise G, Balaban N, Giacometti A. RNAIII-inhibiting peptide affects biofilm formation in a rat model of staphylococcal ureteral stent infection. Antimicrobial Agents and Chemotherapy 2007; 51: 4518-20.
116. Xiong S, Xu G, Xiong W, Hu Q, Zuo P, Shao B, Lan F, Lu X, Xu Y. Lactoferrin-derived peptides and Lactoferricin chimera inhibit virulence factor production and biofilm formation in Pseudomonas aeruginosa. Journal of Applied Microbiology 2010; 109: 1311-8.
117. Clerkin KJ, Tu Z, Kharidia R, Liang JF. Antibacterial peptides with biofilm selective killing activity. Biopolymers 2007; 88: 545-.
118. Ghigo JM, Valle J, Da Re S. Use of bacterial polysaccharides for biofilm inhibition. WO 2008/004128 A2; EP1872791, 2008.
119. Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrobial Agents and Chemotherapy 2009; 53: 3308-16.
120. Babapour A, Yang B, Bahang S, Cao W. Low-temperature sol-gelderived nanosilver-embedded silane coating as biofilm inhibitor. Nanotechnology 2011; 22: 1361-6528.
121. Tyllianakis M, Dalas E, Christofidou M, Kallitsis JK, Chrissanthopoulos A, Koutsoukos PG, Bartzavali C, Gourdoupi N, Papadimitriou K, Oikonomou EK, Yannopoulos SN, Sevastos D. Novel composites materials from functionalized polymers and silver coated titanium oxide capable for calcium phosphate induction, control of orthopedic biofilm infections: an "in vitro" study. Journal of Materials Science-Materials in Medicine 2010; 21: 2201-11.
122. Knetsch MLW, Koole LH. New strategies in the development of antimicrobial coatings: The example of increasing usage of silver and silver nanoparticles. Polymers 2011; 3: 340-66.
123. Herr AB, Conrady DG, Brescia CC, Ward SL. Use of zinc chelators to inhibit biofilm formation. WO 2009/155088, 2009.
124. Musk DJ. Zinc fingered: new compounds that thwart Grampositive biofilm formation by sequestering zinc. Chembiochem 2010; 11: 758-60.
125. Whitekettle WK, Tafel GJ. Biodelivery composition for delivering antimicrobial composition into biofilm in industrial system, comprises liposome structure containing lipid/phospholipid type component, where liposome structure encapsulates antimicrobial composition. US 2010/239627-A1, 2010.
126. Eder F, Groeppel P, Heinl D. Coatings filled with particles, production method and used thereof. WO 2011/020851-A1, 2011.
127. Gottensbos B, Janssen J, Nuijs AM, Brokken D, Gottenbos B. Oral cleaning device for removing dental plaque, has ultrasound transducer which produces ultrasound waves for vibrating bubbles having specific relationship with frequency of ultrasound waves at predetermined frequency. WO 2007/060644-A2; EP 1957003-A2; US 2008/311540-A1; CN 101316563-A; JP 2009/517119-W; CN 101316563-B, 2007.
128. Hatteland K. Combined biofilm and corrosion protection. WO 2010/074580, 2010.
129. Hammann H. Device for impinging flushing section with gas blocks of gases or gas mixture, has compressed gas line, optionally drainage unit following after compressed gas line and filter unit. DE 2010/08056523-A1, 2010.
130. Hammann H. Method for removing biofilms and deposits from pipeline of water system for e.g. pig farming plant, involves penetrating gas blocks as consequences of liquid and gas flows by rinsing section, where blocks are escaped against flows. DE 2010/08048710-A1, 2010.
131. Compere C, Leroy C, Delbarre-Ladrat C, Ghillebaert F, Combes D. Effects of commercial enzymes on the adhesion of a marine biofilm-forming bacterium. Biofouling 2008; 24: 11-22.